BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22593588)

  • 1. Parental origin of the X-chromosome does not influence growth hormone treatment effect in Turner syndrome.
    Devernay M; Bolca D; Kerdjana L; Aboura A; Gérard B; Tabet AC; Benzacken B; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1241-8. PubMed ID: 22593588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of parental origin of the X chromosome on physical phenotypes and GH responsiveness of patients with Turner syndrome.
    Ko JM; Kim JM; Kim GH; Lee BH; Yoo HW
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):66-71. PubMed ID: 20148908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the parental origin of the X chromosome in turner syndrome.
    Sagi L; Zuckerman-Levin N; Gawlik A; Ghizzoni L; Buyukgebiz A; Rakover Y; Bistritzer T; Admoni O; Vottero A; Baruch O; Fares F; Malecka-Tendera E; Hochberg Z
    J Clin Endocrinol Metab; 2007 Mar; 92(3):846-52. PubMed ID: 17192299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.
    Hamelin CE; Anglin G; Quigley CA; Deal CL
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3002-10. PubMed ID: 16757526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome.
    Fiot E; Zenaty D; Boizeau P; Haigneré J; Dos Santos S; Léger J;
    Eur J Endocrinol; 2016 Mar; 174(3):281-8. PubMed ID: 26744895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of parental origin of X chromosome genes on the stature of patients with 45 X Turner syndrome.
    Kochi C; Longui CA; Lemos-Marini SH; Guerra-Junior G; Melo MB; Calliari LE; Monte O
    Genet Mol Res; 2007 Jan; 6(1):1-7. PubMed ID: 17278084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of parental origin of X-chromosome on clinical and biochemical profile in Turner syndrome.
    Malhotra R; Shukla R; Kabra M; Gupta Y; Jyotsna VP; Khadgawat R
    J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1155-1163. PubMed ID: 32813677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
    Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
    Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental origin and mechanism of formation of a 46,X,der(X)(pter-->q21.1::p11.4-->pter)/45,X karyotype in a woman with mild Turner syndrome.
    Binkert F; Spreiz A; Höckner M; Miny P; von Dach Leu B; Erdel M; Zschocke J; Utermann G; Kotzot D
    Fertil Steril; 2010 Jun; 94(1):350.e12-5. PubMed ID: 20117774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girls.
    Gicquel C; Gaston V; Cabrol S; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1472-6. PubMed ID: 9589641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.